Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • 918 Functional heterogeneity o...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
918 Functional heterogeneity of CD4+ tumor-infiltrating lymphocytes

918 Functional heterogeneity of CD4+ tumor-infiltrating lymphocytes

Bibliographic Details
Main Authors: Marco Donia, Mads H Andersen, Martin Lauss, Göran Jönsson, Arianna Draghi, Katja Harbst, Inge Svane, Torben Lorentzen, Shawez Khan, Mario Presti, Christopher A Chamberlain, Agnete WP Jensen, Michael D Crowther, Anne-Christine K Rasmussen, Benedetta Albieri
Format: Article
Language:English
Published: BMJ Publishing Group 2023-11-01
Series:Journal for ImmunoTherapy of Cancer
  • Holdings
  • Description
  • Similar Items
  • Staff View

Similar Items

  • 762 A combination of functional biomarkers improves identification of the tumor-specific reactive T cell repertoire
    by: Marco Donia, et al.
    Published: (2020-11-01)
  • Rapid Identification of the Tumor-Specific Reactive TIL Repertoire via Combined Detection of CD137, TNF, and IFNγ, Following Recognition of Autologous Tumor-Antigens
    by: Arianna Draghi, et al.
    Published: (2021-10-01)
  • 1030 Peripheral immunological dynamics of response in pancreatic cancer treated with immune checkpoint inhibitors
    by: Marco Donia, et al.
    Published: (2023-11-01)
  • Author Correction: Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma
    by: Martin Lauss, et al.
    Published: (2020-04-01)
  • Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma
    by: Martin Lauss, et al.
    Published: (2017-11-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs